|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.229
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.197
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.177
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.177
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.173
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.165
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.165
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.164
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.159
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.155
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.150
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.148
|
|
|
|
positive regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902110 |
11 |
0.147
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.146
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.146
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.144
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.142
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.138
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.135
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.134
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.134
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.134
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.133
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.132
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.131
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.130
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.126
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.125
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.123
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.123
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.121
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.119
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.116
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.115
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.113
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.112
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.111
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.111
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.109
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.109
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.109
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.109
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.109
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.109
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.109
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.107
|
|
|
|
mitochondrial outer membrane permeabilization involved in programmed cell death
|
GO:1902686 |
11 |
0.106
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.106
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.104
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.102
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.102
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.100
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.099
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.098
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.098
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.097
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.097
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.097
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.097
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.095
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.095
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.094
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.094
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.094
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.093
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.093
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.093
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.092
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.091
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.090
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.090
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.089
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.088
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.088
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.086
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.086
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.086
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.086
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.086
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.085
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.085
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.085
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.084
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.083
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.083
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.083
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.083
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.082
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.082
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.081
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.081
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.080
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.079
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
27 |
0.079
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.077
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.076
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.076
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.076
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.076
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.075
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.074
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.074
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.072
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.072
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.072
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.071
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.071
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.070
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.070
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.070
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.070
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.069
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.069
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.069
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.068
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.068
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.068
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.067
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.067
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.067
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.067
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.067
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.066
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.066
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.065
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.065
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.065
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.065
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.065
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.065
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.065
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.064
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.064
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.064
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.064
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.064
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.063
|
|
|
|
positive regulation of lymphocyte apoptotic process
|
GO:0070230 |
13 |
0.063
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.062
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.062
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.062
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.062
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.062
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.061
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.061
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.060
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.060
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.060
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.059
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.059
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.059
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.059
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.059
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.059
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.058
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.058
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.058
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.058
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.058
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.058
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.057
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.057
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.057
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.057
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.057
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.056
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.056
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.056
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.056
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.056
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.056
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.056
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.056
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.056
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.055
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.055
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.055
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.054
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.054
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.054
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.054
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.054
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.054
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.054
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.054
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.054
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.053
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.053
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.053
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.053
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.053
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.052
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.052
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.052
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.051
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.051
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.051
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.051
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.050
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.050
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.050
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.050
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.050
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.049
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.049
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.049
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.049
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.049
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.049
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.049
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.049
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.049
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.049
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.048
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.048
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.048
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.048
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.048
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.048
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.048
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.047
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.047
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.047
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.047
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.046
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.046
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.046
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.046
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.046
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.046
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.045
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.045
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.045
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.045
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.045
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.045
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.044
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.044
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001267 |
4 |
0.044
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
4 |
0.044
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.044
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.044
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.044
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.044
|
|
|
|
positive regulation of mammary gland involution
|
GO:1903521 |
4 |
0.043
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.043
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.043
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.043
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.043
|
|
|
|
b cell apoptotic process
|
GO:0001783 |
19 |
0.043
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.043
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.042
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.042
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.042
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.042
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.042
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.042
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.042
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.042
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.041
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.041
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.041
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.041
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.041
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.041
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.041
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.041
|
|
|
|
positive regulation of mitochondrial membrane permeability
|
GO:0035794 |
12 |
0.040
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.040
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.040
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.040
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.040
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.040
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.040
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.040
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.040
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.040
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.040
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.040
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.039
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.039
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.039
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.039
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.039
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.039
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.039
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.039
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.039
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.039
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.038
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.038
|
|
|
|
regulation of release of cytochrome c from mitochondria
|
GO:0090199 |
11 |
0.038
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.038
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.038
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.038
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.038
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.037
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.037
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.037
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.037
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.037
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.037
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.037
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.037
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.037
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.037
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.037
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.037
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.037
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.036
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.036
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.036
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.036
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.036
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.036
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.036
|
|
|
|
thymocyte apoptotic process
|
GO:0070242 |
19 |
0.036
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.036
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.036
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.035
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.035
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.035
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.035
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.035
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.035
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.034
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.034
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.034
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.034
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.034
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.034
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.034
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.033
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.033
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.033
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.033
|
|
|
|
regulation of mammary gland involution
|
GO:1903519 |
4 |
0.033
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.033
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.033
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.033
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.033
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.033
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.033
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.032
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.032
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.032
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.032
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.032
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.032
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.032
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.032
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.031
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.031
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.031
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.031
|
|
|
|
regulation of mitochondrial membrane permeability
|
GO:0046902 |
17 |
0.031
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.031
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.031
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.031
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.030
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.030
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.030
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.030
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.030
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.030
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.030
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.029
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.029
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.029
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.029
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.029
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.029
|
|
|
|
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
GO:0001844 |
4 |
0.029
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.029
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.029
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.029
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.029
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.029
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.028
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.028
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.028
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.028
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.028
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.028
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.028
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.028
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.028
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.028
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.028
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.028
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.028
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.028
|
|
|
|
regulation of b cell apoptotic process
|
GO:0002902 |
13 |
0.027
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.027
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.027
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.027
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.027
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.027
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.027
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.027
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.027
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.027
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.027
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.027
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.027
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.026
|
|
|
|
regulation of mammary gland epithelial cell proliferation
|
GO:0033599 |
12 |
0.026
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.026
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.026
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.026
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.026
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.026
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.026
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.026
|
|
|
|
negative regulation of retinal cell programmed cell death
|
GO:0046671 |
2 |
0.026
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.026
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.026
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.026
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.026
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.025
|
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.025
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.025
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.025
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.025
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.025
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.025
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.025
|
|
|
|
regulation of execution phase of apoptosis
|
GO:1900117 |
9 |
0.025
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.025
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.025
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.025
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.025
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.025
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.025
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.025
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.025
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.024
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.024
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.024
|
|
|
|
t cell lineage commitment
|
GO:0002360 |
13 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.024
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.024
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.024
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.024
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.024
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.024
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.024
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.024
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.024
|
|
|
|
negative regulation of peptidyl serine phosphorylation
|
GO:0033137 |
10 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.024
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.024
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.024
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.024
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.024
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.024
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.023
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.023
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.023
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.023
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.023
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.023
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.023
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.022
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.022
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.022
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.022
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.022
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
22 |
0.022
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.022
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.022
|
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.022
|
|
|
|
t cell homeostasis
|
GO:0043029 |
35 |
0.022
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.022
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.022
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.022
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.022
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.022
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.021
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.021
|
|
|
|
interaction with host
|
GO:0051701 |
22 |
0.021
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.021
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.021
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.021
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.021
|
|
|
|
modulation by virus of host morphology or physiology
|
GO:0019048 |
3 |
0.021
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.021
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.021
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.021
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
17 |
0.021
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.021
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.021
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.021
|
|
